The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Saved in:
| Title: | The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. |
|---|---|
| Authors: | Cook G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Royle KL; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., O'Connor S; HMDS, Leeds Teaching Hospitals Trust, Leeds, UK., Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Ashcroft AJ; Mid-Yorkshire NHS Trust, Wakefield, UK., Williams CD; Department of Haematology, Centre for Clinical Haematology, Nottingham City Hospitals, Nottingham, UK., Hockaday A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Cavenagh JD; Department of Haematology, Barts & The London NHS Trust, London, UK., Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Ademokun D; Ipswich Hospital NHS Trust, Ipswich, UK., Tholouli E; Department of Haematology, Manchester Royal Infirmary, Manchester, UK., Andrews VE; Medway Maritime Hospital, Kent, UK., Jenner M; University Hospital Southampton NHS Foundation, Southampton, UK., Parrish C; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Yong K; Department of Haematology, University College Hospital, London, UK., Cavet J; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK., Hunter H; Department of Haematology, Plymouth Hospitals Trust, Plymouth, UK., Bird JM; Department of Haematology, University Hospitals Bristol NHS Trust, Bristol, UK., Pratt G; Department of Haematology, Heart of England NHS Trust, Birmingham, UK., Drayson MT; University of Birmingham, Birmingham, UK., Brown JM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Morris TCM; Queen's University, Belfast, UK. |
| Corporate Authors: | National Cancer Research Institute Haemato-oncology Clinical Studies Group |
| Source: | British journal of haematology [Br J Haematol] 2019 May; Vol. 185 (3), pp. 450-467. Date of Electronic Publication: 2019 Feb 06. |
| Publication Type: | Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30729512 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cook+G%22">Cook G</searchLink>; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Royle+KL%22">Royle KL</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22O'Connor+S%22">O'Connor S</searchLink>; HMDS, Leeds Teaching Hospitals Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Cairns+DA%22">Cairns DA</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Ashcroft+AJ%22">Ashcroft AJ</searchLink>; Mid-Yorkshire NHS Trust, Wakefield, UK.<br /><searchLink fieldCode="AU" term="%22Williams+CD%22">Williams CD</searchLink>; Department of Haematology, Centre for Clinical Haematology, Nottingham City Hospitals, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Hockaday+A%22">Hockaday A</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Cavenagh+JD%22">Cavenagh JD</searchLink>; Department of Haematology, Barts & The London NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Snowden+JA%22">Snowden JA</searchLink>; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Ademokun+D%22">Ademokun D</searchLink>; Ipswich Hospital NHS Trust, Ipswich, UK.<br /><searchLink fieldCode="AU" term="%22Tholouli+E%22">Tholouli E</searchLink>; Department of Haematology, Manchester Royal Infirmary, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Andrews+VE%22">Andrews VE</searchLink>; Medway Maritime Hospital, Kent, UK.<br /><searchLink fieldCode="AU" term="%22Jenner+M%22">Jenner M</searchLink>; University Hospital Southampton NHS Foundation, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Parrish+C%22">Parrish C</searchLink>; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Yong+K%22">Yong K</searchLink>; Department of Haematology, University College Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Cavet+J%22">Cavet J</searchLink>; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Hunter+H%22">Hunter H</searchLink>; Department of Haematology, Plymouth Hospitals Trust, Plymouth, UK.<br /><searchLink fieldCode="AU" term="%22Bird+JM%22">Bird JM</searchLink>; Department of Haematology, University Hospitals Bristol NHS Trust, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Pratt+G%22">Pratt G</searchLink>; Department of Haematology, Heart of England NHS Trust, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Drayson+MT%22">Drayson MT</searchLink>; University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Brown+JM%22">Brown JM</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Morris+TCM%22">Morris TCM</searchLink>; Queen's University, Belfast, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22National+Cancer+Research+Institute+Haemato-oncology+Clinical+Studies+Group%22">National Cancer Research Institute Haemato-oncology Clinical Studies Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2019 May; Vol. 185 (3), pp. 450-467. <i>Date of Electronic Publication: </i>2019 Feb 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30729512 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.15782 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 450 Titles: – TitleFull: The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cook G – PersonEntity: Name: NameFull: Royle KL – PersonEntity: Name: NameFull: O'Connor S – PersonEntity: Name: NameFull: Cairns DA – PersonEntity: Name: NameFull: Ashcroft AJ – PersonEntity: Name: NameFull: Williams CD – PersonEntity: Name: NameFull: Hockaday A – PersonEntity: Name: NameFull: Cavenagh JD – PersonEntity: Name: NameFull: Snowden JA – PersonEntity: Name: NameFull: Ademokun D – PersonEntity: Name: NameFull: Tholouli E – PersonEntity: Name: NameFull: Andrews VE – PersonEntity: Name: NameFull: Jenner M – PersonEntity: Name: NameFull: Parrish C – PersonEntity: Name: NameFull: Yong K – PersonEntity: Name: NameFull: Cavet J – PersonEntity: Name: NameFull: Hunter H – PersonEntity: Name: NameFull: Bird JM – PersonEntity: Name: NameFull: Pratt G – PersonEntity: Name: NameFull: Drayson MT – PersonEntity: Name: NameFull: Brown JM – PersonEntity: Name: NameFull: Morris TCM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2019 May Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 185 – Type: issue Value: 3 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |